foxo4-dri senolytic 2024 animal model

foxo4-dri senolytic 2024 animal model The disordered p53 transactivation domain is the target of FOXO4 and the compound FOXO4‐DRI improves the impaired ratio

Name: foxo4-dri senolytic 2024 animal model The disordered p53 transactivation domain is the target of FOXO4 and the compound FOXO4‐DRI improves the impaired ratio
Brand: iglepidom.org
SKU: 27088034056
Price: 23.27 USD
Availability: InStock
Rating: 4.4716000000000005 (15 reviews)

FOXO4DRI improves the impaired ratio of lung cells. The BLMinduced PF Download Scientific Diagram FOXO4 peptide targets myofibroblast ameliorates bleomycininduced pulmonary fibrosis in mice through ECMreceptor interaction pathway Han 2022 Journal of Cellular and Molecular Medicine Wiley Online Library Targeting Cellular Senescence in Aging and Age Related Diseases: Challenges, Considerations, and the Emerging Role of Senolytic and Senomorphic Therapies Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv

SKU: 27088034056 · From iglepidom.org

4.5

USD23.27 USD61.27

Pay in 4 interest-free payments of $5.82 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 5 - Aug 10

Description

Machine Learning in Analytical Chemistry Emerging machine learning (ML) tools process thousands of spectra and chromatograms to identify subtle trends humans might miss